Proton therapy and image-guided precision have improved outcomes for primary brain tumor patients by minimizing toxicity and enhancing targeting accuracy. Multidisciplinary collaboration, involving ...
For more than 25 years, Jeff* and Karen* have called Columbus, OH home. It’s where they raised two children, built deep connections through their local church, and spent countless weekends ...
The CATNON trial showed adjuvant Temodar benefits grade 3 glioma patients, with no added benefit from concurrent chemotherapy, reducing potential toxicity. HER3-DXd, an antibody-drug conjugate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results